NCT05157984

Brief Summary

This is a multicenter investigator-initiated trial between Baylor-Scotts \& White (BSW) and Methodist Health System (MHS). This study will be conducted via a retrospective review and a prospective patient registry. Patients who have undergone the ZPOEM procedure performed by the physicians listed in this protocol will be included, as well as patients who will have this procedure in the future. Data that will be collected at MHS will be entered into an Excel spreadsheet. Patient demographic information will be collected via a review of subjects' electronic medical records. Available patient outcomes will be collected via a review of electronic medical records. This review will be conducted from 1/1/2017 through 12/31/2025.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

June 25, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2024

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

3 years

First QC Date

June 10, 2021

Last Update Submit

March 26, 2024

Conditions

Keywords

Zenker's Diverticulumperoral endoscopic myotomy

Outcome Measures

Primary Outcomes (1)

  • Retrospective chart review / Compartive analyses; t-tests and Wilcoxon-Mann-Whiteney Test; Chi-square or Fisher's exact test; and Pearson correlation coeffecient or Spearman's rank-order correlation

    Retrospective review of patient records who have had ZPOEM procedure, compartive analyses will be performed by employing statistical tests such as t-tests and Wilcoxon-Mann-Whiteney Test; Chi-square or Fisher's exact test; and Pearson correlation coeffecient or Spearman's rank-order correlation depdening on the data distribution. Multivariate analyses will be employed with a p-value \<0.05 will indicate statistical significance.

    January 2017 to December 2025

Secondary Outcomes (1)

  • Prospective follow-up of patients/ Compartive analyses; t-tests and Wilcoxon-Mann-Whiteney Test; Chi-square or Fisher's exact test; and Pearson correlation coeffecient or Spearman's rank-order correlation

    June 2021 to December 2025

Study Arms (2)

Retrospective cohort

Any patient of the physicians listed in this study who has undergone the ZPOEM procedure to treat ZD at Methodist Health System

Procedure: ZPOEM

Prospective cohort

Any patient of the physicians listed in this study who has undergone the ZPOEM procedure to treat ZD at Methodist Health System and has agreed to be follow-up post-procedure.

Procedure: ZPOEM

Interventions

ZPOEMPROCEDURE

Zenker's diverticulum management by Per oral endoscopic myotomy (POEM)

Also known as: peroral endoscopic myotomy (POEM)
Prospective cohortRetrospective cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with Zenker's diverticulum (ZD) and who have undergone the ZPOEM procedure, as well as patients who will have this procedure in the future

You may qualify if:

  • Patients 18 years of age or older
  • Any patient of the physicians listed in this study who has undergone the ZPOEM procedure to treat ZD at MHS
  • For prospective registry: Ability to give informed consent

You may not qualify if:

  • For prospective registry: Unable or not willing to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

Location

MeSH Terms

Conditions

Zenker Diverticulum

Condition Hierarchy (Ancestors)

Diverticulum, EsophagealDiverticulumDiverticular DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Prashant Kedia, MD

    Methodist Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2021

First Posted

December 15, 2021

Study Start

June 25, 2021

Primary Completion

June 28, 2024

Study Completion

June 28, 2024

Last Updated

March 27, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Participant data will be shared only with Baylor, Scott \& White. All data will be de-identified and in compliance with the Data User Agreement in place between both institutions.

Locations